We are live on ! Find out more
FBIO icon

Fortress Biotech

58 hedge funds and large institutions have $27M invested in Fortress Biotech in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

7% more funds holding

Funds holding: 5458 (+4)

0% more ownership

Funds ownership: 0.8%0.81% (+0%)

6% less capital invested

Capital invested by funds: $28.8M → $27M (-$1.79M)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
21
Reduced
11
Closed
8
Calls
$132K
Puts
Net Calls
+$132K
Net Calls Change
+$34K

FBIO Hedge Fund Activity: Q3 2017 in Review

58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2017, worth a combined $27M — down 6.2% from $28.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new FBIO positions and 8 closed out — a net gain of 4 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was Millennium Management, adding an estimated $604K. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.87M sold.

  • 58 institutional investors held Fortress Biotech (FBIO) as of Q3 2017, up from 54 in Q2 2017.
  • Funds reported $27M of Fortress Biotech stock for Q3 2017, down 6.2% quarter-over-quarter.
  • 12 funds opened new Fortress Biotech positions in Q3 2017 and 8 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q3 2017 was Millennium Management, an estimated $604K added.
  • The largest Fortress Biotech seller in Q3 2017 was Avoro Capital Advisors, an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2017.